Yorkville Advisors Global, LP
Position in RNAZ — Transcode Therapeutics, Inc.
CIK 1838613
Mountainside, NJ
Position in RNAZ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$121,958
New position
Shares Held
19,639
first reported quarter
Ownership
0.116%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1
of 8 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Yorkville Advisors Global, LP holds $178,118 across 2 Biotechnology names. RNAZ ranks #1 (68.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RNAZ |
Transcode Therapeutics, Inc.
This page
|
19,639 | $121,958 | |
| 2 | NRSN |
NeuroSense Therapeutics Ltd.
|
78,000 | $56,160 |
All Filings in RNAZ
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $121,958 | 19,639 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||